<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A panel of monoclonal antibodies (BA-1, BA-2 and BA-3) were made against the pre-B <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) cell line NALM-6 </plain></SENT>
<SENT sid="1" pm="."><plain>BA-3 binds to the 100,000 mol. wt <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">common ALL</z:e> antigen (gp100/CALLA), BA-2 binds to a 24,000 mol, wt (p24) cell surface structure and BA-1 binds to a currently undefined antigen </plain></SENT>
<SENT sid="2" pm="."><plain>These antibodies were analysed for their reactivity with 67 human <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>The cell lines studied included <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T ALL</z:e>, non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T ALL</z:e>, surface immunoglobulin+ <z:hpo ids='HP_0001909'>leukemias</z:hpo>/<z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and myeloid/monocytoid <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The results indicate that <z:hpo ids='HP_0000001'>all</z:hpo> three antibodies react primarily (but not exclusively) with malignant cells early in B cell development </plain></SENT>
<SENT sid="5" pm="."><plain>This pattern of reactivity was similar to previous results obtained with fresh, non-cultured malignant cells </plain></SENT>
<SENT sid="6" pm="."><plain>BA-1, BA-2 and BA-3 are useful tools for analysing the developmental options of <z:mpath ids='MPATH_458'>normal</z:mpath> lymphoid cells and for "cleaning up" <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells in selected cases of autologous bone marrow transplantation </plain></SENT>
</text></document>